Changping Wu
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Inflammatory Biomarkers in Disease Prognosis
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 22
- Colorectal Cancer Treatments and Studies 6
- Cancer Immunotherapy and Biomarkers 6
- Inflammatory Biomarkers in Disease Prognosis 4
-
- RNA modifications and cancer 4
- Co-authors
- Jingting Jiang (35 shared papers)Xiao Zheng (12 shared papers)Bin Xu (15 shared papers)Yiting Geng (3 shared papers)Lujun Chen (10 shared papers)Yingjie Shao (5 shared papers)Danxia Zhu (6 shared papers)Yanjie Xu (4 shared papers)
- Journals
- Medicine (5 papers)Oncotarget (4 papers)Cellular Physiology and Biochemistry (4 papers)Oncology Reports (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Changping Wu
59 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 96
- Oncology 1.1k
- Hepatology 288
- Cancer Research 495
- Immunology 517
- Pulmonary and Respiratory Medicine 337
Countries citing papers authored by Changping Wu
This map shows the geographic impact of Changping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changping Wu more than expected).
Fields of papers citing papers by Changping Wu
This network shows the impact of papers produced by Changping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changping Wu. The network helps show where Changping Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Changping Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 259 | |
| 2 | 2016 | 251 | |
| 3 | 2015 | 200 | |
| 4 | 2016 | 190 | |
| 5 | 2017 | 182 | |
| 6 | 2019 | 96 | |
| 7 | 2011 | 81 | |
| 8 | 2021 | 71 | |
| 9 | 2017 | 67 | |
| 10 | 2006 | 65 | |
| 11 | 2016 | 57 | |
| 12 | 2018 | 54 | |
| 13 | 2018 | 52 | |
| 14 | 2018 | 49 | |
| 15 | 2012 | 48 | |
| 16 | Expression of Tim-3 in gastric cancer tissue and its relationship with prognosis. | 2015 | 46 |
| 17 | 2013 | 46 | |
| 18 | 2014 | 43 | |
| 19 | 2016 | 39 | |
| 20 | 2015 | 37 |
About Changping Wu
Changping Wu is a scholar working on Oncology, Molecular Biology, Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 59 papers that have together received 2.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers), Immune Cell Function and Interaction (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Gastric Cancer Management and Outcomes (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Oncology (1.1k citations), Hepatology (288 citations), Cancer Research (495 citations), Immunology (517 citations) and Pulmonary and Respiratory Medicine (337 citations). Changping Wu has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Jingting Jiang, Xiao Zheng, Bin Xu, Yiting Geng, Lujun Chen, Yingjie Shao, Danxia Zhu, Yanjie Xu, Wenting He and Xuefeng Ni. Their work appears in journals such as Medicine, Oncotarget, Cellular Physiology and Biochemistry, Oncology Reports and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.